Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Long-Term Data on Amgen's Prolia
Yahoo/Zacks.com
Tuesday, March 29, 2011 - 8:28am
tags:
Amgen, Prolia, GSK, osteoporosis
Bristol-Myers Squibb: Ipilimumab Approval Brings Positive Surprises
Seeking Alpha
Tuesday, March 29, 2011 - 8:27am
tags:
ipilimumab, Bristol-Myers Squibb, Yervoy
For Biogen Idec, Peace Is Breaking Out on the Shareholder Front
WSJ Online
Monday, March 28, 2011 - 6:29pm
tags:
Biogen Idec, shareholders
Does Amgen Pass Buffett's Test?
Motley Fool
Monday, March 28, 2011 - 5:50pm
tags:
Warren Buffett, Amgen
[video] AZN Increases Target, MENT Rejects Icahn
Forbes
Monday, March 28, 2011 - 5:49pm
tags:
Carl Icahn, AstraZeneca
Spectrum Pharma to continue lymphoma drug study
Yahoo/AP
Monday, March 28, 2011 - 11:46am
tags:
Spectrum Pharmaceuticals, lymphoma, belinostat
Pfizer, Genentech and APP initiate recalls
Fierce Pharma
Monday, March 28, 2011 - 11:45am
tags:
recalls, Pfizer, Genentech, APP
Roche will not be for sale, vice chmn tells paper
Reuters
Monday, March 28, 2011 - 11:43am
tags:
Roche, M&A
YM Biosciences' Worrisome Business Model
Seeking Alpha
Monday, March 28, 2011 - 11:42am
tags:
YM BioSciences, oncology
Zalicus Climbs on New Price Target, Market Waking Up to Company's Value?
Seeking Alpha
Monday, March 28, 2011 - 11:41am
tags:
Zalicus, Prednisporin, Sanofi
Novavax 4Q loss narrows on costs
Yahoo/AP
Monday, March 28, 2011 - 10:59am
tags:
Novavax, earnings
The Supreme Court, Generic Labels & Preemption
Pharmalot
Monday, March 28, 2011 - 10:55am
tags:
Supreme Court, generics, preemption
Big Pharma's Next Decade Won't Be Lost
Seeking Alpha
Monday, March 28, 2011 - 10:54am
tags:
Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly, Merck, Pfizer
Avanir Pharmaceuticals: Uncovering Nuedexta's Potential Part I
Seeking Alpha
Monday, March 28, 2011 - 9:55am
tags:
Nuedexta, Avanir, PBA
Novartis invests in Chinese vaccine maker
In-Pharmatechnologist
Monday, March 28, 2011 - 9:52am
tags:
China, Novartis, vaccines, Zhejiang Tianyuan Bio-Pharmaceutical
3 Biotech Stocks on Our ASCO Watchlist
Seeking Alpha
Monday, March 28, 2011 - 9:49am
tags:
ASCO, Array Biopharma, Spectrum Pharmaceuticals, Ariad Pharmaceuticals
Is Approval of Bristol-Myers Squibb's Yervoy Start of New Chapter at FDA?
Minyanville
Monday, March 28, 2011 - 9:48am
tags:
FDA, Bristol-Myers Squibb, Yervoy, ipilimumab, melanoma
AstraZeneca lifts earnings guidances after tax deal
Marketwatch
Monday, March 28, 2011 - 9:47am
tags:
AstraZeneca, guidance
Making Clinical Trials Less of a Tribulation
WSJ Online
Monday, March 28, 2011 - 9:46am
tags:
clinical trials
First China Pharma well on way to $3m funding
Wired VC
Sunday, March 27, 2011 - 12:18pm
tags:
First China Pharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.